FAFP members are strongly encouraged to read the latest advisory from the AAFP regarding the rescheduling of hydrocodone combination products (HPCs) ARTICLE HERE. Beginning October 6, 2014, HPCs will be moved from schedule III to a more restrictive classification as a schedule II. The FAFP is attempting to determine how Florida laws will impact the change, particularly if electronic prescribing of these HPCs on a monthly basis will be allowed under the new regulations. FAFP members are strongly encouraged to discuss the new regulations with pharmacies to determine how this may impact prescribing patterns for patients under a HPC protocol. More information will be provided as it becomes available.